A293480 Stock Overview
Develops and provides various pharmaceutical products in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Hana Pharm Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩10,680.00 |
| 52 Week High | ₩14,940.00 |
| 52 Week Low | ₩10,120.00 |
| Beta | 0 |
| 1 Month Change | -3.00% |
| 3 Month Change | -5.40% |
| 1 Year Change | -24.89% |
| 3 Year Change | -49.26% |
| 5 Year Change | -48.02% |
| Change since IPO | -64.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| A293480 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -3.6% | 1.4% | -0.8% |
| 1Y | -24.9% | -0.07% | -10.1% |
Return vs Industry: A293480 underperformed the KR Pharmaceuticals industry which returned -3.3% over the past year.
Return vs Market: A293480 underperformed the KR Market which returned -10.9% over the past year.
Price Volatility
| A293480 volatility | |
|---|---|
| A293480 Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A293480 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A293480's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | n/a | Taehong Choi | www.hanaph.co.kr |
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea.
Hana Pharm Co., Ltd. Fundamentals Summary
| A293480 fundamental statistics | |
|---|---|
| Market cap | ₩189.82b |
| Earnings (TTM) | ₩24.30b |
| Revenue (TTM) | ₩139.33b |
0.0x
P/E Ratio0.0x
P/S RatioIs A293480 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A293480 income statement (TTM) | |
|---|---|
| Revenue | ₩139.33b |
| Cost of Revenue | ₩45.33b |
| Gross Profit | ₩94.00b |
| Other Expenses | ₩69.70b |
| Earnings | ₩24.30b |
Last Reported Earnings
Dec 31, 2017
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A293480 perform over the long term?
See historical performance and comparisonDividends
4.8%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 05:28 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2017/12/31 |
| Annual Earnings | 2017/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hana Pharm Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hyoseob Shin | Bookook Securities Co. Ltd |
| Hyoseob Shin | DB Financial Investment Co. Ltd. |
| Seogwon Choi | LS Securities Co., Ltd. |